You are here

candidiasis

FDA approves new antifungal as concerns grow over drug-resistant fungus

BioPharma Dive

Thu, 03/23/23 - 08:53 pm

Cidara Therapeutics

Melinta Therapeutics

FDA advisers back Cidara and Melinta’s antifungal treatment

BioPharma Dive

Thu, 01/26/23 - 10:42 am

Cidara Therapeutics

Melinta Therapeutics

Cidara Therapeutics Initiates Ph III Trial of Rezafungin for Treatment of Invasive Candida Infections

Thu, 09/27/18 - 10:23 am